Skip to main content
Log in

Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In 6 normotensive, healthy male volunteers the pharmacodynamic responses (blood pressure, heart rate; sedation index, tracking test, reaction time) to metoprolol (100 mg bid orally), diazepam (0.1 mg/kg intravenously) and to their combination were studied. The pharmacokinetics of diazepam were also compared in a cross-over experiment, with and without pretreatment by the β-adrenoceptor antagonist to evaluate the possibility of a drug interaction. The pharmacodynamic and pharmacokinetic investigations indicated that metoprolol only slightly impaired the elimination of diazepam (18% decrease in total clearance, 25% increase in elimination half-life). The pharmacodynamics of metoprolol (17% decrease in heart rate, 17% decrease in diastolic RR) was not significantly altered by the bolus injection of diazepam. The extent of prolongation in choice reaction time (RT2) induced by diazepam was significantly (p=0.001) more pronounced following the co-administration of metoprolol. However, the results of RT1, the tracking test and the sedation index did not indicate any increased effect due to the β-blocking agent. It is concluded that concomitant treatment with metoprolol and diazepam causes only minor and clinically irrelevant changes in drug metabolism and drug response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wood AJJ, Feely J (1983) Pharmacokinetic drug interactions with propranolol. Clin Pharmacokinet 8: 253–262

    Google Scholar 

  2. Conrad KA, Byers III JM, Finley PR, Burnham L (1983) Lidocaine elimination: effects of metoprolol and of propranolol. Clin Pharmacol Ther 33: 133–138

    Google Scholar 

  3. Greenblatt DJ, Franke K, Huffman DH (1978) Impairment of antipyrine clearance in humans by propranolol. Circulation 57: 1161–1164

    Google Scholar 

  4. Daneshmend TK, Roberts CJC (1982) The short term effects of propranolol, atenolol and labetolol on antipyrine kinetics in normal subjects. Brit J Clin Pharmacol 13: 817–820

    Google Scholar 

  5. Bax NDS, Lennard MS, Tucker GT (1981) Inhibition of antipyrine metabolism by β-adrenoceptor antagonists. Brit J Clin Pharmacol 12: 779–784

    Google Scholar 

  6. Conrad KA, Nyman DW (1980) Effects of metoprolol and propranolol on theophylline elimination. Clin Pharmacol Ther 28: 463–467

    Google Scholar 

  7. Facino RM, Lanzani R (1979) Interaction of a series of β-adrenergic blocking drugs with rat hepatic microsomal monooxygenase. Pharmacol Res Comm 11: 433–445

    Google Scholar 

  8. Deacon CS, Lennard MS, Max NDS, Woods HF, Tucker GT (1981) Inhibition of oxidative drug metabolism by β-adrenoceptor antagonists is related to their lipid solubility. Brit J Clin Pharmacol 12: 429–431

    Google Scholar 

  9. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347–359

    Google Scholar 

  10. Berman M, Weiss MF (1974) SAAM manual; Laboratory of Theoretical Biology, National Institute of Health Bethesda, USA

    Google Scholar 

  11. Betts TA, Crowe A, Knight R, Raffle A, Parsons A, Blake A, Hawksworth G, Petrie JC (1983) Is there a clinically relevant interaction between diazepam and lipophilic β-blocking drugs? Drugs 25 [Suppl 2]: 279–280

    Google Scholar 

  12. Bax NDS, Lennard MS, Al-Asady S, Deacon CS, Tucker GT, Woods HF (1983) Inhibition of drug metabolism by β-adrenoceptor antagonists. Drugs 25 [Suppl 2]: 121–126

    Google Scholar 

  13. Hallstrom C, Treasaden I, Edwards JG, Lader M (1981) Diazepam, propranolol and their combination in the management of chronic anxiety. Brit J Psychiatr 139: 417–421

    Google Scholar 

  14. Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol. Lancet 1: 520–522

    Google Scholar 

  15. Brunk SF, Delle M, Wilson WR (1974) Effect of propranolol on morphine metabolism. Clin Pharmacol Ther 16: 1039–1044

    Google Scholar 

  16. Ochs HR, Carstens G, Roberts G-M, Greenblatt DJ (1983) Metoprolol or propranolol does not alter the kinetics of procainamide. J Cardiovasc Pharmacol 5: 392–395

    Google Scholar 

  17. Klotz U, Reimann I (1983) Einfluß von Histamin H2-Rezeptor-Antagonisten auf die hepatische Elimination von Arzneimitteln. Klin Wochenschr 61: 625–632

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

supported by the Robert Bosch Foundation, Suttgart, Federal Republic of Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klotz, U., Reimann, I.W. Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol. Eur J Clin Pharmacol 26, 223–226 (1984). https://doi.org/10.1007/BF00630289

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00630289

Key words

Navigation